These earlier results suggested that the effects of the 1+PRN anti-VEGF regimen were not significantly different from those of the 3+PRN regimen in improving the BCVAs and CMTs at 6 or 12 months in eyes with ME associated with retinal vein occlusion [21, 26–29]. Here, VEGFA is linked to retinal vein occlusion.